---
figid: PMC9544900__NEP-27-712-g007
pmcid: PMC9544900
image_filename: NEP-27-712-g007.jpg
figure_link: /pmc/articles/PMC9544900/figure/nep14066-fig-0004/
number: FIGURE 4
figure_title: ''
caption: Immunofluoresence analysis of YAP and heparanase in kidney tissue. (A) Representative
  images of immunofluorescence experimental results. (B) Ratio of immunofluorescence
  intensity of YAP in different groups over WKY group. (C) Ratio of immunofluorescence
  intensity of heparanase in different groups over WKY group. **p < .01 compared to
  the WKY group; the significance of the difference among the other compared groups
  is indicated in the figure. The results were obtained from six rats/group
article_title: Peptide 17 alleviates early hypertensive renal injury by regulating
  the Hippo/YAP signalling pathway.
citation: San‐Bin Xu, et al. Nephrology (Carlton). 2022 Aug;27(8):712-723.
year: '2022'

doi: 10.1111/nep.14066
journal_title: Nephrology (Carlton, Vic.)
journal_nlm_ta: Nephrology (Carlton)
publisher_name: John Wiley & Sons Australia, Ltd

keywords:
- angiotensin II
- hippo/YAP pathway
- hypertension
- peptide 17
- renal damage

---
